Strides Pharma Science Q2 Results: Firm psosts net profit of Rs 94.66 crore

Usa markets CEO Sustainability WhatsApp reports

24.10.2024 - 09:39

Reading now: 355

economictimes.indiatimes.com:

Strides Pharma Science Ltd on Thursday reported a consolidated net profit of Rs 93.66 crore in the second quarter ended September 2024. The company had posted a net loss of Rs 149.45 crore in the corresponding period last fiscal, Strides Pharma Science said in a regulatory filing.
Revenue from operations in the quarter under review stood at Rs 1,201.11 crore as against Rs 999.43 crore in the year-ago period, it added.

Total expenses in the second quarter were higher at Rs 1,097.98 crore as compared to Rs 984.99 crore in the same period a year ago.

Q2FY25 demonstrated sustained growth across all markets fuelled by new product launches. US operations reported the highest-ever quarterly revenue of USD 75 million in Q2FY25, Strides Pharma Science Founder & Executive Chairperson Arun Kumar, and MD & Group CEO Badree Komandur said.

(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com

All news from economictimes.indiatimes.com

About this in other media

Diplomatic recklessness: Did Trump commit a federal crime by calling up Israeli PM Benjamin Netanyahu? Here's all you need to know economictimes.indiatimes.com /1 day ago

Viral video: Trump serves an Indian-origin couple at McDonald's, their heartfelt interaction takes internet by storm economictimes.indiatimes.com /1 day ago

General Motors overcomes US sales drop and China losses to post 3rd quarter profit of $3 billion abcnews.go.com /2 days ago

The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.